comparemela.com

Latest Breaking News On - Zofia piotrowska - Page 3 : comparemela.com

EGFR Exon 20 Insertion Location Could Be Key Factor in NSCLC Treatment

Data showing that the location of EGFR exon 20 insertion mutations impacts patients' responses to Spectrum's poziotinib could have implications for other EGFR inhibitors.

United statesBoehringer ingelheim gilotrifAstrazeneca iressaGenentech tarcevaAstrazeneca tagrissoZofia piotrowskaJohn heymachAmerican society of clinical oncologyDrug administrationMd anderson cancer centerBoehringer ingelheimCancer centerMassachusetts general hospitalCullinan oncologyDizal pharmaceuticalAmerican society

Fibroblasts could serve as new key to enhancing personalized treatment for lung cancer patients

BOSTON – Three subtypes of cancer-associated fibroblasts (CAF) could guide the design of personalized treatment for lung cancer patients, according to

United statesMatthewj niederstLeciav sequistHuidong chenAaronn hataJeffreya engelmanCyrilh benesZofia piotrowskaMedicine at harvard medical schoolGuangzhou health care collaborative innovation majorCancer centerHarvard medical schoolResearch instituteNational human genome research instituteLung cancer research foundationCancer cell

Which Patients Benefit Most From Adjuvant Atezolizumab in NSCLC?

A new analysis of data from IMpower010 has sparked a debate over which patients with early non-small cell lug cancer benefit most.

New yorkUnited statesGeorgetown universityDistrict of columbiaStephenv liuZofia piotrowskaNasser altorkiIchiro yoshinoAmerican society of clinical oncologyHospital cancer centerChiba university hospitalAmerican societyClinical oncologyMedscape medicalWorld conferenceLung cancer

vimarsana © 2020. All Rights Reserved.